. 2021 Dec 24;2021:7230063. doi: 10.1155/2021/7230063

Table 2.

Baseline characteristics of patients in the emergent TAVI group and elective TAVI group.

Study	Sample size	Age, y	Female sex	STS score	Diabetes mellitus	Hypertension	Smoke	COPD	Chronic kidney injury	Dialysis-dependent	Previous stroke or TIA	Previous myocardial infarction	Previous CABG	Atrial fibrillation	Previous PCI	Peripheral vascular disease	NYHA functional class III/IV	Aortic valve area	Mean transvalvular aortic pressure gradient	LVEF
Landes, U. et al	Elective TAVI 342	82.1 ± 6.2	192	7.3 ± 4.5	111	314	—	73	103	—	61	29	68	106	—	54	325	0.63 ± 0.18	51 ± 18	—
Landes, U. et al	Emergent TAVI 27	80.1 ± 9.7	15	9.7 ± 6.1	13	25	—	5	15	—	8	4	6	12	—	6	27	0.59 ± 0.19	52 ± 8.8	—

Kolte, D. et al	Elective TAVI 36,090	83.3 ± 7.4	17474	6.45 ± 3.7	12690	32477	1672	—	—	1195	7520	8253	10212	14664	12531	10948	28641	—	—	57.7 ± 11.1
Kolte, D. et al	Emergent TAVI 3952	83.3 ± 7.4	1902	12.5 ± 7.6	1557	3608	231	—	—	300	887	1323	1000	2002	1395	1302	3656	—	—	49.8 ± 17.1

Ichibori, Y. et al	Elective TAVI 369	81.6 ± 8.5	188	6.4 ± 3.6	160	—	17	97	—	12	55	85	100	135	148	74	268	0.74 ± 0.18	40.8 ± 15.5	53.6 ± 12.9
Ichibori, Y. et al	Emergent TAVI 78	80.8 ± 9.6	38	7.4 ± 4.3	35	—	6	16	—	8	16	19	14	36	27	15	60	0.65 ± 0.17	42.5 ± 16.9	48.2 ± 15.5

Frerker, C. et al	Elective TAVI 744	80 ± 7	395	—	219	620	—	120	283	—	101	—	—	320	—	166	—	0.8 ± 0.3	38.4 ± 15.6	52.4 ± 13.2
Frerker, C. et al	Emergent TAVI 27	78 ± 9	15	—	11	22	—	6	17	—	4	—	—	14	—	9	—	0.7 ± 0.2	35.1 ± 16.8	39.5 ± 15.4

Elbadawi, A. et al	Elective TAVI 10,121	80.6 ± 8.85	4768	—	3699	7978	2987	—	3792	—	—	1354	2237	—	2027	2968	—	—	—	—
Elbadawi, A. et al	Emergent TAVI 10089	81.0 ± 9.05	5072	—	3470	7826	2413	—	4207	—	—	1230	1897	—	1713	2953	—	—	—	—

Alnasser, S. et al	Elective TAVI 152	83 ± 7	—	8.6 ± 4.7	42	132	—	—	—	5	—	37	48	25	—	19	139	0.59 ± 0.18	51.8 ± 15.6	55.0 ± 10.7
Alnasser, S. et al	Emergent TAVI 52	85.75 ± 5.19	—	7.1 ± 4.9	15	42	—	—	—	3	—	21	15	9	—	9	52	0.65 ± 0.16	49.0 ± 16.7	49.9 ± 13.8

Elbaz-Greener, G. et al	Elective TAVI 1741	81.9 ± 7.2	804	—	780	1644	—	618	168	51	—	—	424	442	617	94	—	—	—	—
Elbaz-Greener, G. et al	Emergent TAVI 429	81.3 ± 8.9	192	—	211	395	—	159	75	22	—	—	97	137	121	25	—	—	—	—

Chen, K. et al	Elective TAVI 463	85.3 ± 5.9	192	5.4 ± 2.8	158	414	14	174	—	—	46	136	109	218	—	120	376	0.64 ± 0.22	44.4 ± 11.2	55.6 ± 14.9
Chen, K. et al	Emergent TAVI 139	84.9 ± 6.7	59	7 ± 3.2	54	128	5	50	—	—	17	43	37	66	—	28	120	0.64 ± 0.22	46.4 ± 12.7	50 ± 15

Bianco, V. et al	Elective TAVI 946	82.6 ± 6.7	484	—	387	844	54	77	—	32	222	348	245	388	327	345	680	—	48.5 ± 13.4	—
Bianco, V. et al	Emergent TAVI 247	81.3 ± 8.9	116	—	109	220	28	35	—	22	56	118	72	120	91	83	231	—	49.3 ± 18.3	—

Enta, Y. et al	Elective TAVI 1526	84.3 ± 5.0	1075	6.8 ± 3.4	401	1203	37	282	—	—	211	103	111	308	404	219	740	0.64 ± 0.17	50.5 ± 18.0	58.5 ± 11.9
Enta, Y. et al	Emergent TAVI 87	84.9 ± 7.0	61	14.3 ± 9.6	29	65	7	15	—	—	20	13	9	31	27	27	77	0.56 ± 0.15	50.2 ± 20.0	47.9 ± 16.1

Kabahizi, A. et al	Elective TAVI 975	82.0 ± 2.1	455	4.56 ± 2.69	176	—	—	198	121	16	—	—	140	187	—	229	—	—	—	—
Kabahizi, A. et al	Emergent TAVI 182	80.1 ± 7.0	77	5.79 ± 4.13	40	—	—	34	34	3	—	—	22	42	—	42	—	—	—	—

STS: Society of Thoracic Surgeons Cardiac Surgery Risk Models, COPD: chronic obstructive pulmonary disease, PCI: percutaneous coronary intervention, NYHA: New York Heart Association, LVEF: left ventricular ejection fractions, CABG: coronary artery bypass graft, TIA: transient ischemia attack. Continuous variables were expressed as means ± SD.